Evogene Ltd. , a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries, today announced the ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

The build is an execution milestone following Igneo Infrastructure Partners’ $200 million investment last year in US Signal ...